May 16, 2014 — This policy change would pay for treatment with a combination of new, expensive drugs for patients who haven't responded to older treatment regimens and are approaching or have cirrhosis of the liver.
May 15, 2014 — Two new drugs for hepatitis C can save lives. They are also wildly expensive, costing $66,000 to $84,000 per person. Insurers face paying billions for treatment, or explicitly rationing vital care.
Apr 23, 2014 — Sovaldi has been found to be remarkably effective in curing most patients with common forms of hepatitis C in a matter of months. But the clinical success comes at a high price.
Apr 9, 2014 — About 150 million people worldwide have hepatitis C, and all should be assessed and treated, the World Health Organization says. The cost of screening and drugs means that won't happen soon.
Mar 12, 2014 — Private insurers, as well as those serving Medicaid patients, are wrestling with how to cover the new drugs. Many say they will require prior approval and may be limited to the sickest patients.
Feb 7, 2014 — The U.S. recently approved a drug that can quickly cure hepatitis C in many patients. But its high price means the treatment is out of reach for millions of people in the developing world. Now the pill's manufacturer is talking with Indian producers to reduce the treatment cost to $2,000. But critics say the price drop won't be enough.
Dec 30, 2013 — Earlier this month, the Food and Drug Administration approved a class of drugs that can cure most hepatitis C infections. That's great news for the more than 3 million Americans infected. But the high cost — $84,000 per course of treatment — means some patients could miss out.
Dec 5, 2013 — The first in a new class of drugs that can cure the viral infection that is the leading cause of liver failure and liver cancer is poised for a marketing green light from the Food and Drug Administration. More than 3 million Americans have hepatitis C, but most don't know it.
Mar 29, 2013 — Some 7,000 patients of a Tulsa-area dentist are being urged to get screened for hepatitis and HIV. Health investigators say they found rusty instruments in use and evidence of unsanitary practices.
Mar 27, 2013 — Doctors are desperate for better treatments for hepatitis C, which now affects about 4 million Americans. A new kind of drug that "mops up" molecules in the cells stopped the virus in a small clinical study, offering hope for a quicker cure with few side effects.